AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹5,276 Cr | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr |
What is the latest Total Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹5,276 Cr |
| Mar2025 | ₹3,905 Cr |
| Mar2024 | ₹3,393 Cr |
| Mar2023 | ₹3,235 Cr |
| Mar2022 | ₹3,050 Cr |
How is Total Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,276 Cr | 35.10 | |
| Mar2025 | ₹3,905 Cr | 15.09 | |
| Mar2024 | ₹3,393 Cr | 4.89 | |
| Mar2023 | ₹3,235 Cr | 6.06 | |
| Mar2022 | ₹3,050 Cr | - | |
Compare Total Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹12,261.5 Cr | 1.7% | 14.5% | 63% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 1.7% |
14.5% |
63% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses